Keywords: پس مانده باقی مانده; AG; Abrams/Griffiths; BWT; bladder wall thickness; DO; detrusor overactivity; DWT; detrusor wall thickness; MCC; maximum cystometric capacity; NPV; negative predictive value; PPV; positive predictive value; Pves; vesical pressure; PVR; post-void residual
مقالات ISI پس مانده باقی مانده (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پس مانده باقی مانده; AR; Androgen Receptor; BPH; Benign Prostatic Hyperplasia; LUTS; Lower Urinary Tract Symptoms; PVR; Post-Void Residual; AUR; Acute Urinary Retention; AUASS; American Urological Association Symptom Score; PSA; Prostate Specific Antigen; 5ARI; 5 Alpha Reduct
Keywords: پس مانده باقی مانده; ultrasonography; health expenditures; clinical coding; AMA; American Medical Association; AUA; American Urological Association; CPT®; Current Procedural Terminology; E&M; evaluation and management; ICD; International Classification of Diseases; PVR; post
Keywords: پس مانده باقی مانده; prostatic hyperplasia; transurethral resection of prostate; lasers, solid-state; BPH; benign prostatic hyperplasia; HoLEP; holmium laser enucleation of the prostate; PKRP; plasmakinetic resection of the prostate; PSA; prostate specific antigen; PVR; post-
Postvoid residual predicts the diagnosis of multiple system atrophy in Parkinsonian syndrome
Keywords: پس مانده باقی مانده; Multiple system atrophy; Parkinson's disease; Urodynamic study; Post-void residual;
AUA White Paper on Nonneurogenic Chronic Urinary Retention: Consensus Definition, Treatment Algorithm, and Outcome End Points
Keywords: پس مانده باقی مانده; urinary retention; treatment outcome; AUA; American Urological Association; CUR; nonneurogenic chronic urinary retention; PVR; post-void residual; QIPS; Quality Improvement and Patient Safety Committee; UTI; urinary tract infection;
Surgical Treatment of Female Stress Urinary Incontinence: AUA/SUFU Guideline
Keywords: پس مانده باقی مانده; female; algorithms; urinary incontinence; stress; MUI; mixed urinary incontinence; MUS; mid urethral sling; OAB; overactive bladder; POP; pelvic organ prolapse; PVR; post-void residual; PVS; pubovaginal sling; RCT; randomized controlled trial; RMUS; retro
Male Urethral Stricture: American Urological Association Guideline
Keywords: پس مانده باقی مانده; urethral stricture; urethra; penis; DVIU; direct visual internal urethrotomy; LS; lichen sclerosis; PFUI; pelvic fracture urethral injury; PVR; post-void residual; RUG; retrograde urethrogram; SP; suprapubic; UTI; urinary tract infection; VCUG; voiding cy
Dual Therapy for Refractory Overactive Bladder in Children: AÂ Prospective Open-Label Study
Keywords: پس مانده باقی مانده; urinary bladder; overactive; cholinergic antagonists; mirabegron; EBC; estimated bladder capacity; ECG; electrocardiogram; ER; extended release; OAB; nonneurogenic overactive bladder; PPBC; Patient Perception of Bladder Condition; PVR; post-void residual;
Long-Term Safety and Efficacy of Solifenacin in Children and Adolescents with Overactive Bladder
Keywords: پس مانده باقی مانده; adolescent; child; urinary incontinence; urinary bladder; overactive; solifenacin succinate; AE; adverse event; CNS; central nervous system; DBP; diastolic blood pressure; ECG; electrocardiogram; EoT; end of treatment; FAS; full analysis set; OAB; overact
Breaking the vicious circle: Onabotulinum toxin A in children with therapy-refractory dysfunctional voiding
Keywords: پس مانده باقی مانده; Dysfunctional voiding; Therapy-refractory; Botulinum toxin type A; Paediatrics; BTX-A; Onabotulinum toxin A; DV; Dysfunctional voiding; LUTS; Lower urinary tract symptoms; PVR; Post-void residual; UI; Urinary incontinence; UTI; Urinary tract infection;
Bladder Instillation of Liposome Encapsulated OnabotulinumtoxinA Improves Overactive Bladder Symptoms: A Prospective, Multicenter, Double-Blind, Randomized Trial
Keywords: پس مانده باقی مانده; onabotulinumtoxinA; liposomes; urinary bladder; overactive; AE; adverse event; BoNT; botulinum toxin; GRA; global response assessment; OAB; overactive bladder; OABSS; OAB symptom scores; onaBoNTA; onabotulinumtoxinA; PVR; post-void residual; Qmax; maximum
Urodynamic Effects of Once Daily Tadalafil in Men With Lower Urinary Tract Symptoms Secondary to Clinical Benign Prostatic Hyperplasia: A Randomized, Placebo Controlled 12-Week Clinical Trial
Keywords: پس مانده باقی مانده; prostatic hyperplasia; phosphodiesterase inhibitors; urodynamics; urinary bladder neck obstruction; BOOI; bladder outlet obstruction index; BPH; benign prostatic hyperplasia; BPH-LUTS; LUTS secondary to clinical BPH; ED; erectile dysfunction; I-PSS; Inter
Safety and Tolerability of Solifenacin Add-on Therapy to α-Blocker Treated Men With Residual Urgency and Frequency
Keywords: پس مانده باقی مانده; urinary bladder; overactive; muscarinic antagonists; adrenergic alpha-antagonists; AE; adverse event; BOO; bladder outlet obstruction; BPH; benign prostatic hyperplasia; EOT; end of treatment; I-PSS; International Prostate Symptom Score; LUTS; lower urina
Apport des explorations complémentaires au cours du bilan d’une dysurie de la femme
Keywords: پس مانده باقی مانده; Dysurie; Résidu post-mictionnel; Débimétrie; Aspect de courbe; Étude pression débitBladder outlet obstruction; Post-void residual; Uroflowmetry; Flow pattern; Pressure flow studies
Treatment of Post-Prostatectomy Incontinence With Male Slings in Patients With Impaired Detrusor Contractility on Urodynamics and/or Who Perform Valsalva Voiding
Keywords: پس مانده باقی مانده; urinary incontinence, stress; suburethral slings; prostatectomy; Valsalva maneuver; AUS; artificial urinary sphincter; BCI; bladder contractility index; DO; detrusor overactivity; ICS; International Continence Society; Pabd; abdominal pressure; PdetQmax;
Effects of 100 and 300 Units of Onabotulinum Toxin A on Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Phase II Randomized Clinical Trial
Keywords: پس مانده باقی مانده; prostatic hyperplasia; onabotulinum toxin A; AE; adverse event; AUASI; American Urological Association symptom index; BPH; benign prostatic hyperplasia; LUTS; lower urinary tract symptoms; PVR; post-void residual; Qmax; maximum urinary flow rate;
Proof of Concept Trial of Tanezumab for the Treatment of Symptoms Associated With Interstitial Cystitis
Keywords: پس مانده باقی مانده; tanezumab; nerve growth factor; cystitis; interstitial; antibodies; pain; AE; adverse event; ECG; electrocardiogram; FAS; full analysis set; GRA; global response assessment; IC; interstitial cystitis; ICSI; Interstitial Cystitis Symptom Index; IV; intrave
Current State of Nerve Stimulation Technique for Lower Urinary Tract Dysfunction in Children
Keywords: پس مانده باقی مانده; electric stimulation therapy; transcutaneous electric nerve stimulation; urinary bladder; neurogenic; pediatrics; BC; bladder capacity; CIC; clean intermittent catheterization; DV; dysfunctional voiding; FES; functional electrical stimulation; FW; flowmet
Urodynamic Effects of Once Daily Tadalafil in Men With Lower Urinary Tract Symptoms Secondary to Clinical Benign Prostatic Hyperplasia: A Randomized, Placebo Controlled 12-Week Clinical Trial
Keywords: پس مانده باقی مانده; prostatic hyperplasia; phosphodiesterase inhibitors; urodynamics; urinary bladder neck obstruction; BOOI; bladder outlet obstruction index; BPH; benign prostatic hyperplasia; BPH-LUTS; LUTS secondary to clinical BPH; ED; erectile dysfunction; I-PSS; Inter
Benign Prostatic Obstruction and Parkinson's Disease-Should Transurethral Resection of the Prostate be Avoided?
Keywords: پس مانده باقی مانده; parkinson disease; urinary tract; prostatic hyperplasia; transurethral resection of prostate; BPO; benign prostatic obstruction; CISC; clean intermittent self-catheterization; I-PSS; International Prostate Symptom Score; LUTS; lower urinary tract symptoms